Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • International Academic and Management Association (IAMA) India signs an MoU with the National Commission on Higher Education (NCHE), Liberia Business
  • The Rise of Health Insurance and Why Most Indians Still Go Without It Health
  • Bollywood makes a beeline for Om Books International’s Dr. Neetika Modi-penned ‘Antim: The Last Avatar’ launch Business
  • 4th Somaiya Polymer Science Symposium S4P-4 Celebrates Innovations in Polymer Industry and Academia Business
  • India’s War on Naxalism: A Decade of Grit and Growth National
  • UP Eyes USD 1 Trillion Gau-based Rural Economy Business
  • Easy Boba Expands Footprint in India with New Loyalty Card Initiative and Ongoing Business Growth Business
  • ‘Kantara: Chapter 1’ — A Majestic Return with Legends, but Shadows Lurk Behind the Light Entertainment

Dr Batra’s Launches XOGEN Advance – India’s Fastest and Only Hair Growth Treatment with 10 billion Exosomes

Posted on August 26, 2025 By

New Delhi [India], August 26:  Dr Batra’s®, the pioneers of modern homoeopathy in India, unveiled XOGEN Advance, the latest and most advanced hair regrowth treatment that combines international exosome-based aesthetic treatment with the brand’s rich history of natural, side-effect-free homoeopathic treatment. Designed to treat all types of hair loss and thinning, XOGEN Advance promises visible results in only 4 sessions, without the use of harsh chemicals, minoxidil or invasive surgeries.

Commenting on the launch, Dr. Akshay Batra, Trichologist and Managing Director of Dr Batra’s® Healthcare stated, “Being a patient-centric healthcare provider and a leader in hair health, we constantly strive in bringing world’s most innovative and latest technologies to India that not only enhance patient experience but also ensure outstanding treatment results in the most safe, fast, and cost effective way. There are 40 different types of hair loss, caused by varied factors like medical history, lifestyle, heredity, and genetics, among others. That’s where Dr Batra’s® XOGEN Advance clearly stands out. XOGEN Advance is highly effective in treating all kinds of hair loss, including hereditary hair loss. What enhances its effectiveness is our comprehensive treatment approach of combining homoeopathy with an international range of aesthetic treatments. While homoeopathy addresses the root cause of the hair loss, giving long-term relief, advanced aesthetics treatment like XOGEN Advance offers visible and quicker results.

What makes Dr Batra’s® XOGEN Advance Effective

XOGEN Advance is a highly targeted treatment that is packed with 10 billion exosomes carrying 9100+ growth factors, providing necessary proteins, boosting blood circulation for superior follicle repair and arresting the hair loss. 51200+ mRNA helps combat hereditary hair loss and restart the natural hair re-growth cycle. XOGEN Advance is also infused with Hyaluronic Acid that keeps the scalp hydrated and promotes better texture and shine, thus improving the overall quality of the hair.

A Safe and Side-effect-free Treatment

In the hope of re-growing hair, many people overlook side effects and turn to surgeries, chemical-intensive treatments or dependency on harsh chemicals such as minoxidil. Such treatments have their limitations and often come with side-effects such as scalp & skin irritation, infections, swelling, pain, numbness, itching and scarring. Usage is also not restricted; one may have to continuously be on the routine in many cases.

On the other hand, XOGEN Advance is FDA-approved and holds a US patent as a solution that is entirely non-invasive, secure, and devoid of side effects.

Additionally, XOGEN Advance is a cost-effective treatment. While similar treatments in the market are priced about three to four times higher than the exosome-based treatment. Backed by ‘Dr Batra’s® Best Price Guaranteed’ promise, the treatment offers exceptional value without compromising on quality or outcomes.

This breakthrough builds on Dr Batra’s® legacy of innovation. The brand was the first to introduce exosome-based hair regrowth therapy in India with the launch of XOGEN last year. Now, XOGEN Advance takes this a step further by delivering 10X more exosomes for faster, more effective outcomes as compared to other similar treatments in the market, offering one billion exosomes.

As the only healthcare provider currently offering this advanced treatment in India, Dr Batra’s® continues to lead the way in integrating safe, natural principles with cutting-edge medical science.

About Dr Batra’s® Healthcare

With over 200+ clinics in around 130 cities across 7 countries, including India, Bangladesh, the UK, the UAE, Thailand, Malaysia, and Bahrain, Dr Batra’s® Homeopathy Clinics has over 350 doctors, including skin specialists, hair specialists, and experienced homoeopathic doctors. Dr Batra’s® specializes in Hair, Skin, Allergies, Child and Women’s Health, Mental Health, Sexual Health, and Weight Management ailments including Hair loss, Vitiligo, Psoriasis, Acne, Low immunity, Tonsillitis, Stress Management, Migraine, Thyroid, PCOS, Menopause, Allergies, Sexual Health, Weight Management and Infertility.

For more information, visit www.drbatras.com.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Business Tags:Business

Post navigation

Previous Post: Vantage Announces Launch of India’s First Chartered Global Investment Banking Certification
Next Post: AKK Mahotsav Honoured Torchbearers of Integrity with the Prestigious Character-Tree Award Spearheaded by Swami OMA The Akk

Related Posts

  • Wow! Chicken by Wow! Momo Celebrates Wow! Fried Chicken Day with an Irrestible Offer: Buy 4, Get 8 Pieces of Fried Chicken! Business
  • BNI Prometheus chapter to host Business Conclave on September 2 Business
  • Plumbex India 2025: Strategic Collaborations and Whitepaper Launch to Revolutionize Urban Water Management Business
  • 27th AsiaOne ASEAN Business & Social Forum 2026, Kuala Lumpur, Malaysia Business
  • Pegasus’ 4th showroom now in Surat Business
  • Mind Wars associates with the Ministry of Tourism to conduct a quiz on “Tourism in India” for schools across India Business

Recent Posts

  • AlgoShack Joins Women Entrepreneurship Bootcamp in Namma Davanagere as Startup Partner, Reinforcing Its Commitment to Inclusive Innovation in Karnatak
  • ‘Manoj Jewellers Limited’ is an experienced company engaged in the wholesale and retail jewellery business in Tamil Nadu
  • YAAP Wins Creative & Media Mandate for Parle Candy Culture
  • India’s Spice Industry Is Turning Quality & Traceability Into A Growth Opportunity
  • Containe Technologies Limited Rights Issue to Close on September 25, 2026; Company Aims to Raise Rs. 20.98 Crore

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Trust, Growth, and Legacy: Tarun Ghulati may soon become the first London Mayor of Indian origin after Rishi Sunak became the first UK Prime Minister with Indian roots Business
  • Creality and WOL3D Bring 3D Printing to the Masses Business
  • AFCOM’s Q1 FY26 Mirrors H2 FY25 Performance, Setting the Way for a Strong Year Ahead Business
  • Bollyjammers – Awarded India’s Best Band for Weddings at Wow Awards Asia, 2022 Business
  • Baba Textile Machinery India Pvt. Ltd. Expands Reach with the Grand Opening of its State-of-the-Art Hyderabad Showroom Business
  • Oben Electric Announces ‘Mega Festive Utsav’ with Benefits Worth Rs 35,000 and Assured Rewards on Rorr EZ Sigma and Rorr EZ Business
  • Sundrex Oil Company Ltd.’s Rs. 32.25 crore SME IPO to open for Subscription on December 22, 2025 Business
  • Supreme Power Equipment Limited Opens FY27 with Strong Growth; Revenue Up 37% YoY to ₹48.31 Cr and EBITDA Up 32% to ₹8.89 Cr Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme